GGrantIndex
← Leaderboards

David Morris Colcher

University Of Nebraska Medical Center

Google Scholar ↗PubMed ↗ORCID ↗
$6,573,695
Attributed
$7,574,540
Total exposure
10
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.7M · FY2005–19
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19

Funding mix

By agency

NIH$8,792,773 · 11

By mechanism

P01$5,012,653 · 5
P50$2,293,480 · 3
R44$995,229 · 1
R21$381,635 · 1
P30$109,776 · 1

Top collaborators

Most similar at University Of Nebraska Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Antibodies”

Research focus

AntibodiesCitiesImageImmunotherapeutic AgentIn VivoRadiolabeledAnimalsReagentBaseQuality ControlRadiotracerIn VitroClinical TrialsPreparationTumorMonoclonal AntibodiesProceduresBiodistributionRadiationDrug KineticsHuman ResourcesPrincipal InvestigatorAnimal ResourceInstrumentation

Grant awards (32)

Small Animal Studies Core$60,942
P30 · FY2019 · CA · contact PI
Small Animal Studies Core$46,750
P30 · FY2018 · CA · contact PI
Small Animal Studies Core$2,084
P30 · FY2018 · CA · contact PI
Novel AHCT Regimen for Advanced Hodgkin Lymphoma using Y-90 anti-CD25 with BEAM$174,122
R21 · FY2016 · CA
Biologics Manufacturing Core$216,379
P50 · FY2015 · CA · contact PI
Novel AHCT Regimen for Advanced Hodgkin Lymphoma using Y-90 anti-CD25 with BEAM$207,513
R21 · FY2015 · CA
Biologics Manufacturing Core$190,518
P50 · FY2014 · CA · contact PI
Biologics Manufacturing Core$265,842
P50 · FY2013 · CA · contact PI
Antibody Targeted Radiation and Immunotherapy for the Treatment of Solid Tumors$1,218,233
P01 · FY2012 · CA · contact PI
Clinical Production and IND enabling Studies for PSCA Minibody Imaging in Pancrea$923,853
R44 · FY2012 · CA
Biologics Manufacturing Core$226,778
P50 · FY2012 · CA · contact PI
RADIOPHARMACY AND ASSAYS$211,269
P01 · FY2012 · CA · contact PI
ANIMAL CORE: PHARMACOKINETICS, IMAGING AND THERAPY$135,114
P01 · FY2012 · CA · contact PI
RADIOPHARMACY AND ASSAYS$288,152
P01 · FY2011 · CA · contact PI
ANIMAL CORE: PHARMACOKINETICS, IMAGING AND THERAPY$155,646
P01 · FY2011 · CA · contact PI
Clinical Production and IND enabling Studies for PSCA Minibody Imaging in Pancrea$71,376
R44 · FY2011 · CA
RADIOPHARMACY AND ASSAYS$504,135
P01 · FY2010 · CA · contact PI
ANIMAL CORE: PHARMACOKINETICS, IMAGING AND THERAPY$272,300
P01 · FY2010 · CA · contact PI
RADIOPHARMACY AND ASSAYS$494,263
P01 · FY2009 · CA · contact PI
ANIMAL CORE: PHARMACOKINETICS, IMAGING AND THERAPY$266,959
P01 · FY2009 · CA · contact PI
RADIOPHARMACY AND ASSAYS$479,620
P01 · FY2008 · CA · contact PI
ANIMAL CORE: PHARMACOKINETICS, IMAGING AND THERAPY$259,070
P01 · FY2008 · CA · contact PI
Animal Models and Assays$225,736
P50 · FY2008 · CA · contact PI
RADIOPHARMACY AND ASSAYS$472,615
P01 · FY2007 · CA · contact PI
ANIMAL CORE: PHARMACOKINETICS, IMAGING AND THERAPY$255,277
P01 · FY2007 · CA · contact PI
Animal Models and Assays$218,258
P50 · FY2007 · CA · contact PI
Animal Models and Assays$118,470
P50 · FY2006 · CA · contact PI
Animal Models and Assays$115,020
P50 · FY2005 · CA
Animal Models and Assays$111,670
P50 · FY2004 · CA
USE OF VASOACTIVE PEPTIDES TO MODIFY MONOCLONAL ANTIBODY PHARMACOLOGY$201,603
P50 · FY2002 · CA
USE OF VASOACTIVE PEPTIDES TO MODIFY MONOCLONAL ANTIBODY PHARMACOLOGY$201,603
P50 · FY2001 · CA
USE OF VASOACTIVE PEPTIDES TO MODIFY MONOCLONAL ANTIBODY PHARMACOLOGY$201,603
P50 · FY2000 · CA